TENET HEALTHCARE CORP (THC) executive Lisa Y. Foo, EVP and Chief Operating Officer, reported selling 24,000 shares of common stock on August 31, 2026, in an open-market transaction at a weighted average price of $266.32 per share. After these sales, she directly holds 8,053 shares of Tenet Healthcare common stock. The shares were sold in multiple trades at prices ranging from $266.02 to $266.95 per share.
TENET HEALTHCARE CORP (THC) director Cecil D. Haney reported a charitable transfer of company stock. On 2026-08-28, he made a bona fide gift of 150 shares of Tenet Healthcare common stock, with no sale proceeds received, to a charitable donor advised fund. Following this transaction, he directly holds 12,403 shares of Tenet Healthcare common stock.
TENET HEALTHCARE CORP (THC) received a Rule 144 notice from officer Lisa Foo for a proposed sale of up to 24,000 shares of common stock through Fidelity Brokerage Services LLC on or about August 31, 2026. The shares, with an aggregate market value of $6,391,579.07, relate to restricted stock vesting as compensation on several dates in 2025 and 2026. The notice also reports that Foo sold 10,000 shares on July 29, 2026 for $2,580,295.03, and that 80,519,000 shares of Tenet common stock are outstanding.
TENET HEALTHCARE CORP (THC) reported that director Cecil D. Haney sold 1,300 shares of common stock on 2026-08-24. The sale was reported as a non-derivative transaction in an open market or private transaction at a price of $278.03 per share, leaving him with 12,553 directly held shares. The Rule 10b5-1 checkbox was left unchecked, and no footnotes were provided.
TENET HEALTHCARE CORP (THC) reported that CEO and director Saumya Sutaria sold a total of 100,000 shares of common stock in open-market or private transactions on August 24–25, 2026. The sales occurred at weighted-average prices with trade ranges between $272.65 and $279.14 per share, and detailed price breakdowns are available upon request.
Tenet Healthcare Corp (THC) is named as the issuer in a notice that Saumya S. Sutaria intends to sell common stock under Rule 144. The filing indicates a planned sale of 50,000 common shares of Tenet Healthcare through Fidelity Brokerage Services LLC on the NYSE around 08/25/2026. The shares to be sold are linked to restricted stock vesting awards received from the issuer as compensation, including 47,162 shares vesting on 02/23/2025 and 2,838 shares vesting on 03/01/2024. The notice also reports a prior sale during the past three months of 50,000 common shares on 08/24/2026.
TENET HEALTHCARE CORP (THC) is the issuer of common stock that Cecil D. Haney, a director, has notified an intent to sell under Rule 144. The notice covers 1,300 shares of common stock through Fidelity Brokerage Services LLC on the NYSE, with an aggregate market value of $361,439.00 and referencing 80,519,000 shares outstanding and an approximate sale date of 08/24/2026.
The shares to be sold were acquired from the issuer as compensation via restricted stock vesting events of 322 shares on 05/07/2024 and 978 shares on 05/23/2025.
TENET HEALTHCARE CORP (THC) received a notice under Rule 144 for a proposed resale of its common stock for the account of Saumya S. Sutaria through Fidelity Brokerage Services LLC. The notice covers up to 50,000 shares of common stock with an aggregate market value of $13,935,240.26, with an approximate sale date of August 24, 2026. Shares of common stock outstanding were 80,519,000 at the time referenced, which is a baseline figure, not the amount being sold. The securities to be sold were acquired as compensation through restricted stock vesting on three dates in early 2025.
T. Rowe Price Associates, Inc. reported beneficial ownership of 7,954,926 shares of Tenet Healthcare Corp common stock, representing 9.2% of the class. The firm reported sole voting power over 7,857,098 shares and sole dispositive power over 7,954,926 shares, with no shared voting or dispositive power.
T. Rowe Price Associates stated that this filing should not be construed as an admission that it is the beneficial owner of these securities, and such beneficial ownership is expressly denied.
Tenet Healthcare Corp director Tammy Romo reported two open-market sales of Common Stock. On 2026-08-07, she sold 2,500 shares at $260.83 per share, and on 2026-08-06 she sold 4,922 shares at $264.15 per share, totaling 7,422 shares sold. Both positions were reported as direct ownership; post-transaction holdings were not stated.